Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon-alpha. Irani YD, Hughes A, Kok CH, Clarson J, et al. Br J Haematol 2023;202:1127-1136.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Irani YD, Hughes A, Kok CH, Clarson J, et al. Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon-alpha. Br J Haematol 2023;202:1127-1136.
PMID: 37482935